- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TOMDF
Recent news which mentions TOMDF
Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
October 27, 2022
From Benzinga
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
September 12, 2022
From Benzinga
Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases
August 11, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022
April 27, 2022
Tickers
TOMDF
From Benzinga
Todos Medical To Present At The Emerging Growth Conference
April 25, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics
April 21, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group
April 20, 2022
Tickers
TOMDF
From Benzinga
From Benzinga
Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants
April 04, 2022
Tickers
TOMDF
From Benzinga
UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
April 04, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
April 01, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Reports Case Study Of Patient With Long COVID
March 31, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma
March 16, 2022
Tickers
TOMDF
From Benzinga
Todos Medical To Present At The Emerging Growth Conference
March 15, 2022
Tickers
TOMDF
From Benzinga
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
From Benzinga
Benzinga Announces This Week's All Access Guests
February 10, 2022
From Benzinga
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
From Benzinga
Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
January 24, 2022
Tickers
TOMDF
From Benzinga
PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID®
January 19, 2022
Tickers
TOMDF
From Benzinga
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022
From Benzinga
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
January 11, 2022
Tickers
TOMDF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.